Jennifer Possick, MD
she/her/hers
Associate Professor Term; Medical Director, Winchester Center for Lung Disease, Winchester Center for Lung Disease
Research & Publications
Biography
News
Coauthors
Selected Publications
- Welcome to the Real World Understanding the Many Faces of Osimertinib-Related PneumonitisPossick J. Welcome to the Real World Understanding the Many Faces of Osimertinib-Related Pneumonitis. CHEST Journal 2022, 162: 965-967. PMID: 36344125, DOI: 10.1016/j.chest.2022.06.020.
- Pulmonary Complications of ImmunotherapyBade BC, Possick JD. Pulmonary Complications of Immunotherapy. Clinics In Chest Medicine 2020, 41: 295-305. PMID: 32402364, DOI: 10.1016/j.ccm.2020.02.012.
- Knowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor–related Pneumonitis. An Official American Thoracic Society Research StatementSears CR, Peikert T, Possick JD, Naidoo J, Nishino M, Patel SP, Camus P, Gaga M, Garon EB, Gould MK, Limper AH, Montgrain PR, Travis WD, Rivera MP. Knowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor–related Pneumonitis. An Official American Thoracic Society Research Statement. American Journal Of Respiratory And Critical Care Medicine 2019, 200: e31-e43. PMID: 31518182, PMCID: PMC6775885, DOI: 10.1164/rccm.201906-1202st.
- Pulmonary Disease in Non-Pulmonary MalignancyCheng GS, Possick JD. Pulmonary Disease in Non-Pulmonary Malignancy. Clinics In Chest Medicine 2017, 38: xiii-xiv. PMID: 28477646, DOI: 10.1016/j.ccm.2017.03.001.
- Pulmonary Toxicities from Checkpoint Immunotherapy for MalignancyPossick JD. Pulmonary Toxicities from Checkpoint Immunotherapy for Malignancy. Clinics In Chest Medicine 2017, 38: 223-232. PMID: 28477635, DOI: 10.1016/j.ccm.2016.12.012.
- Pulmonary Complications of Lung Cancer TreatmentMcAvoy K, Possick J. Pulmonary Complications of Lung Cancer Treatment. 2023, 229-254. DOI: 10.1007/978-3-031-38412-7_11.
- A Novel Ambulatory Curriculum for Pulmonary and Critical Care Fellows Utilizing Adult Learning Theory and Multi-disciplinary TeachersMcavoy K, Honiden S, Possick J. A Novel Ambulatory Curriculum for Pulmonary and Critical Care Fellows Utilizing Adult Learning Theory and Multi-disciplinary Teachers. 2023, a4303-a4303. DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4303.
- A Clinic Blueprint for Post-Coronavirus Disease 2019 RECOVERY Learning From the Past, Looking to the FutureLutchmansingh DD, Knauert MP, Antin-Ozerkis DE, Chupp G, Cohn L, Dela Cruz CS, Ferrante LE, Herzog EL, Koff J, Rochester CL, Ryu C, Singh I, Tickoo M, Winks V, Gulati M, Possick JD. A Clinic Blueprint for Post-Coronavirus Disease 2019 RECOVERY Learning From the Past, Looking to the Future. CHEST Journal 2020, 159: 949-958. PMID: 33159907, PMCID: PMC7641526, DOI: 10.1016/j.chest.2020.10.067.
- Cardiovascular, pulmonary, and metabolic toxicities complicating tyrosine kinase inhibitor therapy in chronic myeloid leukemia: Strategies for monitoring, detecting, and managingMedeiros BC, Possick J, Fradley M. Cardiovascular, pulmonary, and metabolic toxicities complicating tyrosine kinase inhibitor therapy in chronic myeloid leukemia: Strategies for monitoring, detecting, and managing. Blood Reviews 2018, 32: 289-299. PMID: 29454474, DOI: 10.1016/j.blre.2018.01.004.
- Chapter 15 Diagnosis and Management of Treatment-Related Pulmonary ComplicationsPossick J. Chapter 15 Diagnosis and Management of Treatment-Related Pulmonary Complications. 2018, 221-241. DOI: 10.1016/b978-0-323-48565-4.00015-1.
- Distinguishing features of long COVID identified through immune profilingKlein J, Wood J, Jaycox J, Dhodapkar R, Lu P, Gehlhausen J, Tabachnikova A, Greene K, Tabacof L, Malik A, Silva Monteiro V, Silva J, Kamath K, Zhang M, Dhal A, Ott I, Valle G, Peña-Hernández M, Mao T, Bhattacharjee B, Takahashi T, Lucas C, Song E, McCarthy D, Breyman E, Tosto-Mancuso J, Dai Y, Perotti E, Akduman K, Tzeng T, Xu L, Geraghty A, Monje M, Yildirim I, Shon J, Medzhitov R, Lutchmansingh D, Possick J, Kaminski N, Omer S, Krumholz H, Guan L, Dela Cruz C, van Dijk D, Ring A, Putrino D, Iwasaki A. Distinguishing features of long COVID identified through immune profiling. Nature 2023, 623: 139-148. PMID: 37748514, PMCID: PMC10620090, DOI: 10.1038/s41586-023-06651-y.
- Differences in Mortality Among Patients With Asthma and COPD Hospitalized With COVID-19Liu Y, Rajeevan H, Simonov M, Lee S, Wilson F, Desir G, Vinetz J, Yan X, Wang Z, Clark B, Possick J, Price C, Lutchmansingh D, Ortega H, Zaeh S, Gomez J, Cohn L, Gautam S, Chupp G. Differences in Mortality Among Patients With Asthma and COPD Hospitalized With COVID-19. The Journal Of Allergy And Clinical Immunology In Practice 2023, 11: 3383-3390.e3. PMID: 37454926, PMCID: PMC10787810, DOI: 10.1016/j.jaip.2023.07.006.
- Mortality Differences Among Patients With Airway Disease Hospitalized With COVID-19Liu Y, Rajeevan H, Simonov M, Wilson F, Desir G, Vinetz J, Yan X, Wang Z, Clark B, Possick J, Price C, Lutchmansingh D, Gomez J, Cohn L, Gautam S, Chupp G. Mortality Differences Among Patients With Airway Disease Hospitalized With COVID-19. 2023, a6297-a6297. DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a6297.
- Proteomic profiling demonstrates inflammatory and endotheliopathy signatures associated with impaired cardiopulmonary exercise hemodynamic profile in Post Acute Sequelae of SARS‐CoV‐2 infection (PASC) syndromeSingh I, Leitner B, Wang Y, Zhang H, Joseph P, Lutchmansingh D, Gulati M, Possick J, Damsky W, Hwa J, Heerdt P, Chun H. Proteomic profiling demonstrates inflammatory and endotheliopathy signatures associated with impaired cardiopulmonary exercise hemodynamic profile in Post Acute Sequelae of SARS‐CoV‐2 infection (PASC) syndrome. Pulmonary Circulation 2023, 13: e12220. PMID: 37091121, PMCID: PMC10113513, DOI: 10.1002/pul2.12220.
- “Long Haulers”Lutchmansingh D, Sevilla J, Possick J, Gulati M. “Long Haulers”. Seminars In Respiratory And Critical Care Medicine 2023, 44: 130-142. PMID: 36646091, DOI: 10.1055/s-0042-1759568.
- AMBULATORY BLOCK STRUCTURE TO IMPROVE FELLOW OUTPATIENT PULMONARY MEDICINE EXPOSURE AND EDUCATIONMCAVOY K, POSSICK J, HONIDEN S. AMBULATORY BLOCK STRUCTURE TO IMPROVE FELLOW OUTPATIENT PULMONARY MEDICINE EXPOSURE AND EDUCATION. CHEST Journal 2022, 162: a2599. DOI: 10.1016/j.chest.2022.08.2124.
- Impaired Stressed Blood Volume Augmentation in Post-COVID-19 PatientsSavarimuthu S, Joseph P, Lutchmansingh D, Possick J, Gulati M, Cullinan M, Kreiger J, Heerdt P, Singh I. Impaired Stressed Blood Volume Augmentation in Post-COVID-19 Patients. 2022, a5418-a5418. DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a5418.
- Abstract 6991: Impaired Systemic Oxygen Extraction Relates to Reduced Exercise Capacity in Post-COVID-19 Long Hauler SyndromeBiondi M, Joseph P, Gulati M, Possick J, Lutchmansingh D, Cullinan M, Heerdt P, Singh I. Abstract 6991: Impaired Systemic Oxygen Extraction Relates to Reduced Exercise Capacity in Post-COVID-19 Long Hauler Syndrome. Circulation 2021, 144: a6991-a6991. DOI: 10.1161/circ.144.suppl_1.6991.
- UNEXPLAINED DYSPNEA IN A PATIENT WITH A HISTORY OF COVID-19Biondi M, Gulati M, Possick J, Joseph P, Singh I, Lutchmansingh D. UNEXPLAINED DYSPNEA IN A PATIENT WITH A HISTORY OF COVID-19. CHEST Journal 2021, 160: a2373-a2374. PMCID: PMC8503500, DOI: 10.1016/j.chest.2021.07.2054.
- Persistent Exertional Intolerance After COVID-19 Insights From Invasive Cardiopulmonary Exercise TestingSingh I, Joseph P, Heerdt PM, Cullinan M, Lutchmansingh DD, Gulati M, Possick JD, Systrom DM, Waxman AB. Persistent Exertional Intolerance After COVID-19 Insights From Invasive Cardiopulmonary Exercise Testing. CHEST Journal 2021, 161: 54-63. PMID: 34389297, PMCID: PMC8354807, DOI: 10.1016/j.chest.2021.08.010.
- Teaching Communication SkillsPossick J, Akgün K. Teaching Communication Skills. 2019, 195-212. DOI: 10.1007/978-3-030-10680-5_11.
- Imatinib-Induced Pneumonitis Associated with "Radiation-Recall" Pattern in a Patient with Chronic Myelogenous Leukemia and Prior Chemotherapy, Radiation Therapy, and Immunotherapy for Non-Small Cell Lung CancerNaiditch H, Brandsdorfer C, Possick J. Imatinib-Induced Pneumonitis Associated with "Radiation-Recall" Pattern in a Patient with Chronic Myelogenous Leukemia and Prior Chemotherapy, Radiation Therapy, and Immunotherapy for Non-Small Cell Lung Cancer. 2019, a1472-a1472. DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a1472.
- Should Physicians New to a Case Counsel Patients and Their Families to Change Course at the End of Life?Honiden S, Possick J. Should Physicians New to a Case Counsel Patients and Their Families to Change Course at the End of Life? The AMA Journal Of Ethic 2018, 20: e699-707. PMID: 30118419, DOI: 10.1001/amajethics.2018.699.
- A Young Man With Hemoptysis and Cavitary Lung LesionsBrady VA, Zinchuk AV, Siegel MD, Possick JD. A Young Man With Hemoptysis and Cavitary Lung Lesions. CHEST Journal 2018, 153: e85-e88. PMID: 29626974, PMCID: PMC6026285, DOI: 10.1016/j.chest.2017.09.018.
- Sarcoidosis Following Anti-PD-1 and Anti-CTLA-4 Therapy for Metastatic MelanomaReddy SB, Possick JD, Kluger HM, Galan A, Han D. Sarcoidosis Following Anti-PD-1 and Anti-CTLA-4 Therapy for Metastatic Melanoma. Journal Of Immunotherapy 2017, 40: 307-311. PMID: 28737620, DOI: 10.1097/cji.0000000000000181.
- Pulmonary Disease in Non-Pulmonary MalignancyCheng G, Possick J. Pulmonary Disease in Non-Pulmonary Malignancy. Clinics In Chest Medicine 2017, 38: i. DOI: 10.1016/s0272-5231(17)30011-4.
- Pneumococcal Vaccination Strategies. An Update and PerspectiveBerical AC, Harris D, Dela Cruz CS, Possick JD. Pneumococcal Vaccination Strategies. An Update and Perspective. Annals Of The American Thoracic Society 2016, 13: 933-944. PMID: 27088424, PMCID: PMC5461988, DOI: 10.1513/annalsats.201511-778fr.
- Pneumonitis in non-small cell lung cancer (NSCLC) patients treated with programmed death 1 (PD1) axis inhibitors.Gettinger S, Zhang X, Homer R, Possick J, Wurtz A, Goldberg S, Chiang A, Herbst R, Rubinowitz A. Pneumonitis in non-small cell lung cancer (NSCLC) patients treated with programmed death 1 (PD1) axis inhibitors. Journal Of Clinical Oncology 2016, 34: 9030-9030. DOI: 10.1200/jco.2016.34.15_suppl.9030.
- Systemic Manifestations and Comorbidities of Chronic Obstructive Pulmonary DiseaseMost J, Possick J, Rochester C. Systemic Manifestations and Comorbidities of Chronic Obstructive Pulmonary Disease. Clinical Pulmonary Medicine 2014, 21: 155-166. DOI: 10.1097/cpm.0000000000000044.
- Advances in the Outpatient Management of Chronic Obstructive Pulmonary DiseasePossick J, Most J, Rochester C. Advances in the Outpatient Management of Chronic Obstructive Pulmonary Disease. Clinical Pulmonary Medicine 2013, 20: 259-270. DOI: 10.1097/cpm.0000000000000001.
- Intensive Care Unit Management of Status AsthmaticusMarshall P, Possick J, Chupp G. Intensive Care Unit Management of Status Asthmaticus. Clinical Pulmonary Medicine 2009, 16: 293-301. DOI: 10.1097/cpm.0b013e3181bdff38.
- Effect of Variation in CHI3L1 on Serum YKL-40 Level, Risk of Asthma, and Lung FunctionOber C, Tan Z, Sun Y, Possick JD, Pan L, Nicolae R, Radford S, Parry RR, Heinzmann A, Deichmann KA, Lester LA, Gern JE, Lemanske RF, Nicolae DL, Elias JA, Chupp GL. Effect of Variation in CHI3L1 on Serum YKL-40 Level, Risk of Asthma, and Lung Function. New England Journal Of Medicine 2008, 358: 1682-1691. PMID: 18403759, PMCID: PMC2629486, DOI: 10.1056/nejmoa0708801.